CordovaCann (LVRLF) Cost of Revenue (2018 - 2019)

CordovaCann (LVRLF) recorded quarterly Cost of Revenue of $5676.5 in Q2 2019, down 1.59% quarter-over-quarter from $5768.1 in Q1 2019, and little changed on a YoY basis from $5687.3 in Q2 2018.

CordovaCann (LVRLF) Cost of Revenue (2018 - 2019) Analysis & Trends

CordovaCann's Cost of Revenue history runs 2 years deep, the most recent figure standing at $5676.5 for Q2 2019.

  • In Q2 2019, Cost of Revenue changed 0.19% year-over-year to $5676.5; the TTM figure through Jun 2019 stood at $23062.8 (up 171.2% YoY), while the FY2025 annual figure was $7.2 million, up 0.72% from the prior year.
  • Cost of Revenue was $5676.5 for Q2 2019 at CordovaCann, down from $5768.1 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $5933.7 in Q4 2018 to a low of $2816.7 in Q1 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 696.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 641.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 133.40 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 34.44 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 13.80 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 586.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 155.56 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 52.68 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 222.00 Mn
10 CordovaCann - - - -

Historic Data

Download Data
DateValue
Jun 30, 2019 5,676.51
Jun 30, 2019 5,676.51
Mar 31, 2019 5,768.13
Mar 31, 2019 5,768.13
Dec 31, 2018 5,933.68
Dec 31, 2018 5,933.68
Sep 30, 2018 5,684.50
Sep 30, 2018 5,684.50
Jun 30, 2018 5,687.34
Jun 30, 2018 5,687.34
Mar 31, 2018 2,816.69
Mar 31, 2018 2,816.69